Medical and Pharmaceutical

62% of respondents said they rather use cannabis than pharmaceuticals when treating a medical issue

The 50mg bottle contains 30mg of CBN and 10mg of THC per mg

The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients

Canadian company set to focus clinical trials down under, announces regulatory update

Many distributors are choosing not to test their products for microbes, pesticides and heavy metals

NOYA produces brands such as Cookies, Lemonnade, Minntz and GAGE

The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations

Curaleaf currently operates in 23 states and has 130 dispensaries

The company's products will specifically be offered to patients undergoing cancer and neurological treatments

The first smart machine is expected to pop up in June 2022

Mac 1 is the first Canadian cannabis product to enter the European market via the Cantourage platform

The oil is now available at the Jardin, Vegas Tree House, and Exhale pot shops in Las Vegas

The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds

But whether or not the disruption helps with the substance's antidepressant properties still needs further research

Since opening in March, the firm says its clinic has already seen 800 patients

The company is also launching a roll-on product for symptom relief

The company says the certification will help boost domestic sales and secure further licensing internationally

And the Supreme Court will debate fully decriminalizing cannabis cultivation for medical purposes

Researchers tested some of the cannabinoid's most promising medical properties in a lab setting

Health authorities are recommending patients not to inhale

After starting treatment with pot, average opioid consumption dropped by 27%

But experts say the official decree is 'legally fragile' and could be thrown out by the high court

The parliamentary group has until May 20 to submit a report to inform future policy

Patients First is a response to U.K. patients voicing frustrations over the quality of legal medical cannabis

The research will take place at the Icahn School of Medicine at Mount Sinai, New York

'Psychedelic-assisted therapy will be an integral part of mental wellness therapeutic models in the very near future,' says one of the program's coordinators

Extracts and cannabis with THC above 0.2% remain illegal

The firm says Canadian patients will get broader access to its products, as it continues to push for international growth

Upwards of 112,000 Albanians have weighed in on the question

It appeared Health Canada was increasing access to the substance, but recent events suggest otherwise

Patients are being encouraged to transfer to Mendo Cannabis

The study adds to a body of emerging research suggesting pot is effective in reducing opioid use

Patients' health-related quality of life typically improves across a broad spectrum of chronic conditions

Despite South Dakotans voting for cannabis reform in 2020, their governor and lawmakers have challenged the resulting laws

It appears the company will continue operations through its Agro Greens business in Saskatchewan

Most states only allow doctors to prescribe pot based on a list of qualifying conditions

Lawmakers and industry groups have called on the president to not veto the currently proposed bill

About 1.3M people in the UK have long Covid

Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects

The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say